Martin Schoen MD MPH

@mwschoen

Hematology/Oncology and Outcomes Research, Saint Louis University and St. Louis Veterans Affairs Medical Center, prostate cancer-myeloma modeling/data science

Saint Louis, MO, USA martinschoen.com Joined June 2009

239 Following 662 Followers 787 Posts

Latest posts 5

Martin Schoen MD MPH @mwschoen Feb 26

Observational Study of U.S. Veterans With mCSPC Shows OS Benefit of ADT + ARPI in Patients Who Are Elderly, Frail, or Affected by Substantial Comorbidities dailynews.ascopubs.org/do/observation…
bit.ly/4qVMZam

dailynews.ascopubs.org Observational Study of U.S. Veterans With mCSPC Shows OS Benefit of ADT + ARPI in Patients Who Are... An observational study of U.S. veterans with metastatic CSPC demonstrated that adding an androgen receptor pathway inhibitor to androgen deprivation therapy (ADT) is associated with significant OS...

Martin Schoen MD MPH @mwschoen Feb 26

Classic view of the bay bridge in SF this morning @ASCO #GU26 @TylerSbrt 🏃 by 🌊 @RenuEapen

Martin Schoen MD MPH @mwschoen Nov 11, 2025

Real-world data from @DeptVetAffairs helps to understand trends and inform practice. Survival in metastatic prostate cancer is increasing, likely due to use of androgen receptor pathway inhibitors. Now we show no difference in OS between abiraterone and enzalutamide @HarshrajL

Survival is improving in metastatic prostate cancer over the last 20 years, especially in younger patients

The use of ARPIs are increasing in metastatic prostate cancer, over 50% in 2021

There is no difference in survival with abiraterone compared to enzalutamide

Martin Schoen MD MPH @mwschoen Jun 3, 2025

Great job @ariananaaseh with your poster on male and female breast cancer in the @DeptVetAffairs that included over 2000 men and 13000 women. Shows men are older when diagnosed and have more advanced disease with shorter survival. Great collaboration of @slusom and @washusurgres

Martin Schoen MD MPH @mwschoen Jun 2, 2025

Super proud of @im_slu @slusom resident Sumrah Khan and her poster on tumor suppressor gene mutations and Lu-PSMA-177, which are associated with inferior survival in @DeptVetAffairs supported by @PCFnews and @CDMRP